260 related articles for article (PubMed ID: 16552574)
41. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
[TBL] [Abstract][Full Text] [Related]
42. The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Hasegawa K; Okamoto H; Kawamura K; Kato R; Kobayashi Y; Sekiya T; Udagawa Y
Eur J Obstet Gynecol Reprod Biol; 2012 Jul; 163(1):67-70. PubMed ID: 22480411
[TBL] [Abstract][Full Text] [Related]
43. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196
[TBL] [Abstract][Full Text] [Related]
44. Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine.
Disel U; Gürkut O; Abali H; Kaleağasi H; Mertsoylu H; Ozyilkan O; Saif MW
Cutan Ocul Toxicol; 2010 Jun; 29(2):140-2. PubMed ID: 20298142
[TBL] [Abstract][Full Text] [Related]
45. Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study.
Morganti AG; Picardi V; Ippolito E; Massaccesi M; Macchia G; Deodato F; Mattiucci GC; Caravatta L; Di Lullo L; Giglio G; Tambaro R; Mignogna S; Caprino P; Ingrosso M; Sofo L; Cellini N; Valentini V
Acta Oncol; 2010 May; 49(4):418-22. PubMed ID: 20397772
[TBL] [Abstract][Full Text] [Related]
46. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
47. Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study.
Koukourakis MI; Simopoulos C; Pitiakoudis M; Lyratzopoulos N; Romanidis K; Giatromanolaki A; Polychronidis A; Kouklakis G; Sivridis E; Minopoulos G; Manolas K
Anticancer Res; 2008; 28(5B):3035-40. PubMed ID: 19031952
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Torigoe S; Fukumitsu T; Mizobe T; Yamashita N; Yanagawa T; Shirouzu K
J Surg Oncol; 2006 Jan; 93(1):47-55. PubMed ID: 16353181
[TBL] [Abstract][Full Text] [Related]
49. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
50. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.
Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R
Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489
[TBL] [Abstract][Full Text] [Related]
51. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.
Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J
World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463
[TBL] [Abstract][Full Text] [Related]
52. A phase II study of second-line neoadjuvant chemotherapy with capecitabine and radiation therapy for anthracycline-resistant locally advanced breast cancer.
Gaui MF; Amorim G; Arcuri RA; Pereira G; Moreira D; Djahjah C; Biasoli I; Spector N
Am J Clin Oncol; 2007 Feb; 30(1):78-81. PubMed ID: 17278899
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
Yamada H; Iinuma H; Watanabe T
Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
[TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer.
Layman RM; Thomas DG; Griffith KA; Smerage JB; Helvie MA; Roubidoux MA; Diehl KM; Newman LA; Sabel MS; Hayman JA; Pierce LJ; Hayes DF; Schott AF
Clin Cancer Res; 2007 Jul; 13(14):4092-7. PubMed ID: 17634534
[TBL] [Abstract][Full Text] [Related]
55. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
Freedman GM; Meropol NJ; Sigurdson ER; Hoffman J; Callahan E; Price R; Cheng J; Cohen S; Lewis N; Watkins-Bruner D; Rogatko A; Konski A
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1389-93. PubMed ID: 17394942
[TBL] [Abstract][Full Text] [Related]
56. Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Lee SJ; Choi YL; Park YH; Kim ST; Cho EY; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2011 Sep; 68(3):743-51. PubMed ID: 21170649
[TBL] [Abstract][Full Text] [Related]
57. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
[TBL] [Abstract][Full Text] [Related]
58. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
60. Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.
Domingo E; Lorvidhaya V; de Los Reyes R; Syortin T; Kamnerdsupaphon P; Lertbutsayanukul C; Vito-Cruz E; Tharavichitkul E; Jin K; Yoshihara M; Cupino N; Lertsanguansinchai P
Oncologist; 2009 Aug; 14(8):828-34. PubMed ID: 19661184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
